Global Allergy Diagnostics Market valued at $4.9 bn is set to witness a healthy growth rate of 11%

Contact Us
Avez Shaikh
121/7E Avenue Franklin Roosevelt 1050 Brussels, Be
Brussels 1050 
Phone:32 498868079

The prevalence of allergic diseases globally has continued to grow in the industrialized world for more than 50 years. Allergies are the 6th leading cause of chronic illness in the U.S. and each year more than 50 million Americans experience various types of allergies. Continuously rising cases of allergic diseases and other related medical conditions has fueled the global allergy diagnostics market.

Growing Prominence of mHealth in Allergy Diagnosis & Allergy Care

The widespread availability of technology-based interventions such as mobile health in the clinical setting has enabled patients to play an active role in their medical care. Mobile health (mHealth) utilizes mobile communication devices such as computers, tablets and smartphones to improve patient education & self-management of diseases, help in remote surveillance of patient’s health, flow of data and information and disease management from first diagnosis to an optimized treatment.

Advent of patient-facing mHealth technologies (such as apps) is expected to favorably impact clinical, economic and process outcomes. Features such as medication reminders, educational content, games-based self management, symptom diaries, electronic sensors, patient self-tracking dashboards, voice recognition, wearable technology, pollen sensors, and virtual reality offered by apps not only improves patient knowledge but also improves medication adherence, asthma and allergic conditions control, quality of life and results in fewer unscheduled office visits.

mHealth offers allergists and patients a new mode of communication via the phone camera, sound recording system, motion sensors, texting, and by using diagnostic devices and diagnostic algorithms incorporated in the smartphone itself.

Competitive Landscape Analysis: Allergy Diagnostics Market

Some of the key players operating in the allergy diagnostics market are Thermo Fisher Scientific Inc., Siemens Healthineers , Danaher, Omega Diagnostics Group PLC, bioMérieux SA, Romer Labs Division Holding, EUROIMMUN Medizinische Labordiagnostika AG, HollisterStier Allergy, NEOGEN Corporation, Eurofins Scientific, Minaris Medical America, Inc., Stallergenes Greer, HOB Biotech Group Corp., Ltd., HYCOR Biomedical, R-Biopharm AG, AESKU.GROUP GmbH, ACON Laboratories, Inc., Lincoln Diagnostics, Inc., Astra Biotech GmbH, Erba Group (UK), among others.

Get Customized Report on Allergy Diagnostics Market @